Biotechs are coming to the island as tariffs threaten overseas drug exports, and finding Puerto Rico is more than just a leading manufacturing hub.

In a report released today, from Oppenheimer maintained a Buy rating on Amgen, with a price target of $380.00. The company’s shares closed yesterday at $300.08. Elevate Your Inv ...

Truist Financial analyst Srikripa Devarakonda maintained a Hold rating on Amgen today. The company’s shares closed yesterday at $300.08. Elevate Your Investing Strategy: Take ad ...

The Children's and Youth Life Science Education Program 'Grow-up, Bio-up Season 5 (hereinafter referred to as Grow-up, Bio-up ...

Amgen Inc. reported a robust quarterly performance, surpassing analyst expectations with a notable revenue increase of 9.4%. ...

Amgen Inc. (NASDAQ:AMGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Amgen Inc. (NASDAQ:AMGN) reported ...

The outlook for the gastric cancer treatment market appears favorable, fueled by progress in targeted therapies and immunotherapies. Traditionally, p ...

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...